These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4117364)

  • 21. Sex comparison of heme pathway in rats bearing hepatic tumors.
    Wainstok de Calmanovici R; Cochón AC; Aldonatti C; Cabral JR; San Martín de Viale LC
    Tumori; 1991 Oct; 77(5):379-84. PubMed ID: 1781034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect.
    Felsher BF; Kushner JP
    Semin Hematol; 1977 Apr; 14(2):243-51. PubMed ID: 323986
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolism as a prerequisite for the porphyrinogenic action of polyhalogenated aromatics, with special reference to hexachlorobenzene and polybrominated biphenyls (Firemaster BP-6).
    Debets FM; Hamers WJ; Strik JJ
    Int J Biochem; 1980; 12(5-6):1019-25. PubMed ID: 6256219
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biosynthesis of heme: regulation; hereditary and experimental porphyrias].
    Grandchamp B; Nordmann Y
    Expos Annu Biochim Med; 1980; 34():45-80. PubMed ID: 7009205
    [No Abstract]   [Full Text] [Related]  

  • 25. Fast track to the porphyrias.
    Phillips JD; Kushner JP
    Nat Med; 2005 Oct; 11(10):1049-50. PubMed ID: 16211036
    [No Abstract]   [Full Text] [Related]  

  • 26. Porphyrin biosynthesis. Enhancement of the fractional catabolic rate of microsomal haem in chemically induced porphyria.
    Meyer UA; Marver HS
    S Afr Med J; 1971 Sep; ():175-7. PubMed ID: 5150273
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent advances in porphyrin metabolism.
    Pindyck J; Kappas A; Levere RD
    CRC Crit Rev Clin Lab Sci; 1971; 2(4):639-57. PubMed ID: 4944524
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of substrates for glycine acyltransferase, and the role of sulfanilamide and acetate in the reversal of chemically-induced porphyria in the rat.
    Tephly TR; Condie LW; Piper WN
    Enzyme; 1973; 16(1):187-95. PubMed ID: 4791042
    [No Abstract]   [Full Text] [Related]  

  • 29. Porphyrin synthesis in drug induced hepatic porphyria.
    Rao MR; Padmanaban G; Sarma PS
    Biochem Pharmacol; 1971 Aug; 20(8):2001-7. PubMed ID: 5137957
    [No Abstract]   [Full Text] [Related]  

  • 30. Thyroid function and thyroxine metabolism in hexachlorobenzene-induced porphyria.
    Kleiman de Pisarev DL; Rios de Molina MC; San Martin de Viale LC
    Biochem Pharmacol; 1990 Mar; 39(5):817-25. PubMed ID: 2310407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of environmental lighting on porphyrin hepatic metabolism in the rat.
    Jones K; Magnus IA
    Acta Biol Med Ger; 1979; 38(9):1295-9. PubMed ID: 550667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic porphyrias: new findings on the nature of metabolic defects.
    Meyer UA
    Prog Liver Dis; 1976; 5():280-93. PubMed ID: 775544
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of iron and copper on porphyrin metabolism and hepatic structure].
    Irigoyen EH; Bercovich C; Costa JA
    Medicina (B Aires); 1979; 39(1):43-8. PubMed ID: 530082
    [No Abstract]   [Full Text] [Related]  

  • 34. Hexachlorobenzene-induced porphyria in rats--relationship between prophyrin excretion and induction of drug metabolizing liver enzymes.
    Lissner R; Goerz G; Eichenauer MG; Ippen H
    Biochem Pharmacol; 1975 Sep; 24(18):1731-3. PubMed ID: 1191331
    [No Abstract]   [Full Text] [Related]  

  • 35. Dissociation between stainable marrow and liver iron following iron-dextran therapy.
    Ali M; Fayemi AO; Laraia S; Kasper V
    J Med Soc N J; 1982 Apr; 79(4):319-21. PubMed ID: 6952012
    [No Abstract]   [Full Text] [Related]  

  • 36. Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: a biochemical and morphological study.
    Siersema PD; van Helvoirt RP; Ketelaars DA; Cleton MI; de Bruijn WC; Wilson JH; van Eijk HG
    Hepatology; 1991 Dec; 14(6):1179-88. PubMed ID: 1959868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental porphyria. I. The experimental porphyrias--a group of distinctive metabolic lesions.
    Sweeney GD; Janigan D; Mayman D; Lai H
    S Afr Med J; 1971 Sep; ():68-72. PubMed ID: 4113777
    [No Abstract]   [Full Text] [Related]  

  • 38. Experimental hepatic porphyria induced by hexachlorobenzene as a model for human symptomatic porphyria.
    Stonard MD
    Br J Haematol; 1974 Aug; 27(4):617-25. PubMed ID: 4138791
    [No Abstract]   [Full Text] [Related]  

  • 39. Allylisopropylacetamide-induced propyria-protective effect of 3,5-dimethylisooxazole.
    Pinelli A; Favalli L
    Biochem Pharmacol; 1973 Apr; 22(7):797-801. PubMed ID: 4692646
    [No Abstract]   [Full Text] [Related]  

  • 40. [Porphyria].
    Ho TT
    Ned Tijdschr Geneeskd; 1972 Jun; 116(25):1048-57. PubMed ID: 4556517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.